Editorial Statement About JCCAP’s 2023 Special Issue on Informant Discrepancies in Youth Mental Health Assessments: Observations, Guidelines, and Future Directions Grounded in 60 Years of Research

Issue 1 of the 2011 Volume of the Journal of Clinical Child and Adolescent Psychology (JCCAP) included a Special Section about the use of multi-informant approaches to measure child and adolescent (i.e., hereafter referred to collectively as “youth”) mental health (De Los Reyes, 2011). Researchers collect reports from multiple informants or sources (e.g., parent and peer, youth and teacher) to estimate a given youth’s mental health. The 2011 JCCAP Special Section focused on the most common outcome of these approaches, namely the significant discrepancies that arise when comparing estimates from any two informant’s reports (i.e., informant discrepancies). These discrepancies appear in assessments conducted across the lifespan (Achenbach, 2020). That said, JCCAP dedicated space to understanding informant discrepancies, because they have been a focus of scholarship in youth mental health for over 60 years (e.g., Achenbach et al., 1987; De Los Reyes & Kazdin, 2005; Glennon & Weisz, 1978; Kazdin et al., 1983; Kraemer et al., 2003; Lapouse & Monk, 1958; Quay et al., 1966; Richters, 1992; Rutter et al., 1970; van der Ende et al., 2012). Thus, we have a thorough understanding of the areas of research for which they reliably appear when clinically assessing youth. For instance, intervention researchers observe informant discrepancies in estimates of intervention effects within randomized controlled trials (e.g., Casey & Berman, 1985; Weisz et al., 2017). Service providers observe informant discrepancies when working with individual clients, most notably when making decisions about treatment planning (e.g., Hawley & Weisz, 2003; Hoffman & Chu, 2015). Scholars in developmental psychopathology observe these discrepancies when seeking to understand risk and protective factors linked to youth mental health concerns (e.g., Hawker & Boulton, 2000; Hou et al., 2020; Ivanova et al., 2022). Thus, the 2011 JCCAP Special Section posed a question: Might these informant discrepancies contain data relevant to understanding youth mental health? Suppose none of the work in youth mental health is immune from these discrepancies. In that case, the answer to this question strikes at the core of what we produce―from the interventions we develop and implement, to the developmental psychopathology research that informs intervention development

Suplementação da Silagem de Sorgo com Diferentes Fontes de Proteína para Bovinos de Corte Supplementation of Sorghum Silage with Different Sources of Protein for Beef Cattle

Farelo de soja (FS), farinha de penas (FPH) e farelo de soja tratado (FST) com 0,17% de formaldeído foram utilizados como suplementos à silagem de sorgo para avaliar os seus efeitos sobre o consumo, o desempenho e a digestibilidade aparente dos nutrientes em bovinos machos. O tratamento do farelo de soja com formaldeído não diferiu do farelo de soja não tratado para todos os ítens estudados. Por outro lado, a farinha de penas apresentou menores coeficientes de digestibilidade para a MS, MO, PB, FDN e FDA (63,0; 64,9; 61,80; 56,4; e 50,9% versus 65,1; 67,0; 66,8; 58,5; e 53,6% do FS e 66,7; 68,7; 67,2; 61,9; e 57,5% do FST, respectivamente), além de propiciar menor consumo de energia metabolizável por unidade de tamanho metabólico (214 kcal/UTM para a FPH, 234 kcal/UTM para o FS e de 240 kcal/UTM para o FST). Mesmo com estas diferenças nos parâmetros acima mencionados, não foi possível detectar diferenças para o ganho de peso dos animais, de 1,5; 1,6 e 1,7 kg/dia para FPH, FS e FST, respectivamente.<br>Soybean meal (SBM), feather meal (FTM) and treated soybean meal (TSBM) with 0.17% of formaldehyde were used as supplement of sorghum silage to evaluate the effect on intake, performance and nutrient digestibilities with young bulls. Treatment of soybean meal with formaldehyde did not differ from soybean not treated, for all studied parameters. Feather meal supplement presented lower digestibility coefficients for DM, OM, CP, NDF and ADF (63.0, 65.5, 61.8, 56.4, and 50.9%, versus 65.1, 67.0, 66.8, 58.5, and 53.6% for soybean meal and 66.7, 68.7, 67.2, 61.9 and 57.5% for treated soybean meal, respectively). It also showed lower metabolizable energy intake by unit of metabolic weight (214 kcal/MW for FTM, 234 kcal/MW for SBM and 240 kcal/MW for TSBM). Even if differences were observed for all parameters, it was not possible to detect differences in live weight gain (1.5, 1.6 and 1.7 kg/d for FTM, SBM and TSBM)

International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia

International audienceBackground HHT is an autosomal dominant disease with an estimated prevalence of at least 1/5000 which can frequently be complicated by the presence of clinically significant arteriovenous malformations in the brain, lung, gastrointestinal tract and liver. HHT is under-diagnosed and families may be unaware of the available screening and treatment, leading to unnecessary stroke and life-threatening hemorrhage in children and adults. Objective The goal of this international HHT guidelines process was to develop evidence-informed consensus guidelines regarding the diagnosis of HHT and the prevention of HHT-related complications and treatment of symptomatic disease. Methods The overall guidelines process was developed using the AGREE framework, using a systematic search strategy and literature retrieval with incorporation of expert evidence in a structured consensus process where published literature was lacking. The Guidelines Working Group included experts (clinical and genetic) from eleven countries, in all aspects of HHT, guidelines methodologists, health care workers, health care administrators, HHT clinic staff, medical trainees, patient advocacy representatives and patients with HHT. The Working Group determined clinically relevant questions during the pre-conference process. The literature search was conducted using the OVID MEDLINE database, from 1966 to October 2006. The Working Group subsequently convened at the Guidelines Conference to partake in a structured consensus process using the evidence tables generated from the systematic searches. Results The outcome of the conference was the generation of 33 recommendations for the diagnosis and management of HHT, with at least 80% agreement amongst the expert panel for 30 of the 33 recommendations